26 May 2013
Keywords: Valeant, OraPharma, Oral health, M&A, Term loan
Article | 18 June 2012
Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) said Friday that it has agreed to acquire OraPharma, a USA-based specialty ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.